Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Casdin Capital, LLC
Form 13F · Q2 2026

Casdin Capital, LLC

CIK 1534261Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$2.0B
Reported book value
43
Positions
12
Quarters on record
Top 50
Positions

Casdin Capital, LLC — holdings

Top 43 positions of 43, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1RVMD Revolution Medicines Inc2.6M+0.0%$483M24.2%
2RLAY Relay Therapeutics Inc16.0M+11.2%$300M15.0%
3WGS Genedx Holdings Corp3.7M+23.3%$254M12.7%
4BIOLIFE SOLUTIONS INC Biolife Solutions Inc4.7M−21.9%$131M6.6%
5ILMN Illumina Inc530,000+0.0%$93M4.7%
6LAB Standard Biotools Inc88.8M+0.0%$73M3.7%
7GPCR Structure Therapeutics Inc1.2M+0.0%$63M3.2%
8DNLI Denali Therapeutics Inc2.0M+11.1%$53M2.6%
9NGNE Neurogene Inc1.5M+8.8%$49M2.4%
10BEAM Beam Therapeutics Inc1.4M+0.0%$46M2.3%
11TXG 10X Genomics Inc1.1M−53.8%$40M2.0%
12SRRK Scholar Rock Hldg Corp665,000+90.0%$37M1.8%
13PSNL Personalis Inc2.5M+59.4%$34M1.7%
14GRAL Grail Inc480,000+108.7%$33M1.6%
15GH Guardant Health Inc185,000−41.3%$28M1.4%
16MAZE Maze Therapeutics Inc843,857+11.2%$25M1.3%
17HIMS Hims & Hers Health Inc700,000+0.0%$24M1.2%
18ALNY Alnylam Pharmaceuticals Inc75,000+0.0%$23M1.1%
19TSHA Taysha Gene Therapies Inc3.2M+0.0%$22M1.1%
20AGMB Agomab Therapeutics Nv1.6M+0.0%$20M1.0%
21SEPN Septerna Inc553,268+0.0%$19M0.9%
22PBLS Parabilis Medicines Inc645,690—$18M0.9%
23SION Sionna Therapeutics Inc400,000—$18M0.9%
24VCYT Veracyte Inc276,308+0.0%$16M0.8%
25ANL Adlai Nortye Ltd1.2M+132.1%$14M0.7%
26PRME Prime Medicine Inc3.2M+0.0%$12M0.6%
27ABSI Absci Corporation973,260+0.0%$11M0.6%
28DGX Quest Diagnostics Inc50,000+0.0%$11M0.5%
29SRPT Sarepta Therapeutics Inc470,000—$8M0.4%
30UNIQURE NV Uniqure Nv150,000—$7M0.3%
31NTLA Intellia Therapeutics Inc355,000+0.0%$6M0.3%
32MRNA Moderna Inc75,000+0.0%$5M0.3%
33IRON Disc Medicine Inc65,000+0.0%$5M0.2%
34GLUE Monte Rosa Therapeutics Inc186,014+0.0%$5M0.2%
35IPSC Century Therapeutics Inc1.2M+0.0%$3M0.2%
36CTNM Contineum Therapeutics Inc148,333+0.0%$2M0.1%
37BBOT Bridgebio Oncology Therapeut282,312+0.0%$2M0.1%
38EDIT Editas Medicine Inc445,000—$1M0.1%
39PACIFIC BIOSCIENCES CALIF IN Pacific Biosciences Calif In723,767+0.0%$1M0.1%
40KARD Kardigan Inc50,000—$1M0.1%
41RXRX Recursion Pharmaceuticals In165,323+0.0%$606,7350.0%
42DNA Ginkgo Bioworks Holdings Inc36,493+0.0%$361,6460.0%
43TNYA Tenaya Therapeutics Inc361,969+0.0%$267,5310.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.